SCHEMBL2876171

SCHEMBL2876171

CNC(=O)C1=Cc2c[nH]c3nccc(c23)N(C(C)=O)C1

nearest known ligand 0.41

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CDC42BPB Q9Y5S2 19/20 0.41
ROCK1 Q13464 18/20 0.41
ROCK2 O75116 17/20 0.41
JAK2 O60674 1/20 0.36
CDC42BPA Q5VT25 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2876524 0.87 ROCK1 (0.36) CDC42BPBROCK1ROCK2CDC42BPA
SCHEMBL2873623 0.79 NPC1 (0.42) ROCK1ROCK2
SCHEMBL2876778 0.78 AKT1 (0.41) ROCK1ROCK2
SCHEMBL2878622 0.77 MMP13 (0.44) ROCK1ROCK2
SCHEMBL2870920 0.77 AKT1 (0.35) ROCK1ROCK2
SCHEMBL2877177 0.77 ROCK2 (0.41) ROCK1ROCK2JAK2
SCHEMBL2874794 0.76 JAK2 (0.40) CDC42BPBROCK1ROCK2JAK2CDC42BPA
SCHEMBL2877014 0.76 JAK2 (0.40) CDC42BPBROCK1ROCK2JAK2CDC42BPA
SCHEMBL2877100 0.76 ROCK2 (0.39) CDC42BPBROCK1ROCK2
SCHEMBL2875905 0.76 ROCK2 (0.42) CDC42BPBROCK1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2002836-B1 Cyclocondensed azaindoles active as kinase inhibitors NERVIANO MEDICAL SCIENCES SRL (IT) 2010-10-20 EP claimed
EP-2002836-A1 Cyclocondensed azaindoles active as kinase inhibitors Nerviano Medical Sciences S.r.l. (IT) 2008-12-17 EP claimed
EP-2002836-B1 Cyclocondensed azaindoles active as kinase inhibitors NERVIANO MEDICAL SCIENCES SRL (IT) 2010-10-20 EP disclosed
EP-2002836-A1 Cyclocondensed azaindoles active as kinase inhibitors Nerviano Medical Sciences S.r.l. (IT) 2008-12-17 EP disclosed